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Abstract 
Background: Nonsuicidal self‑injury (NSSI) is a frequent and clinically relevant phenomenon in adolescence. Within 
Europe, Germany has one of the highest prevalence rates in youth with lifetime prevalence ranging between 25 and 
35%. However, treatment guidelines for NSSI are not yet available.
Methods: Consensus based clinical guidelines were created by a working group consisting of members of eleven 
medical, psychological or psychotherapeutic professional national associations, and two members of patient self‑help 
and prevention groups. The guidelines were developed in consecutive expert meetings and literature searches and 
agreed on in a final consensus conference.
Results: Given that evidence on both the psychotherapeutic and psychopharmacological treatment of NSSI is 
limited, a consensus based approach was chosen. The consensus indicated that due to the accumulating evidence on 
the efficacy of psychotherapeutic approaches, core elements of psychotherapy should be provided in treatment of 
NSSI. A specific psychopharmacological therapy of NSSI cannot be recommended. In addition, the guidelines provide 
recommendations for surgical intervention of NSSI.
Conclusions: In accordance with the heterogeneous level of evidence, recommendations for the clinical manage‑
ment of NSSI in adolescence were made during a consensus conference after reviewing available literature. There is 
still a lack of knowledge on prevention as well as clinical interventions, which needs to be addressed by further clini‑
cally relevant studies.
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Background
Both public and researcher awareness of and interest in 
nonsuicidal self-injury (NSSI) has increased in recent 
years, especially since adoption of the term NSSI as a 
new diagnostic entity in section three of the fifth edi-
tion of the diagnostic and statistical manual (DSM 5) [1]. 
The DSM 5 criteria define NSSI as repetitive (occurring 
on more than 5 days within 1 year), direct altering body 
tissue in a non-socially sanctioned manner, and as being 
undertaken without suicidal intent [1].
In the past, different definitions were used to describe 
self-injurious behavior with or without suicidal intent, 
among them terms like “parasuicide”, “self-mutilation” 
or “self-wounding” [2]. To date, many studies use terms 
like “Deliberate Self-Harm” (DSH), which includes all 
forms of self-injurious behavior regardless of its suicidal 
intent [3], and can best be viewed as an “umbrella term” 
[4] for self-harming behaviors, also including NSSI and 
nonsuicidal self-poisoning, which is not captured in NSSI 
[5]. It somehow resembles the definition of “parasuicide” 
provided by Power and Spencer [6], who stated that par-
asuicide “is a variable concept, both in terms of suicidal 
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intent […] and medical lethality” [6, p. 228], whereas it 
has been argued that terms like para-suicide were “super-
seded” by “deliberate self-harm” “in recognition that not 
all episodes involved definite suicidal intent” [7, p. 326].
There is still an ongoing discussion as to whether the 
inclusion of NSSI in the DSM 5 is warranted or not. On 
the one hand, creating a category of NSSI can prevent 
especially adolescents from being automatically “labeled” 
as having borderline personality disorder, and acknowl-
edges the fact that self-injury can be undertaken without 
suicidal intent and that consensus-based pathways can be 
developed for best practice treatment [8, 9]. On the other 
hand, it has been argued that a clear distinction between 
non-suicidal and suicidal intent is often not possible and 
that there can be ambivalence towards the question of 
suicidal intent [7]. The ongoing debate on these issues is 
unsettled and it has been stated in a review on the stud-
ies using the DSM 5 criteria that some criteria still need 
clarification [10]. However, the debate about the valid-
ity of NSSI has been fruitful, as it created many studies 
focusing on the association of NSSI and suicidality [11], 
often describing NSSI as risk factor for suicide attempts 
[12], preceding them [5, 13]. In comparison to adoles-
cents “only” reporting NSSI, those reporting a combina-
tion of NSSI and a history of a suicide attempts reported 
sexual abuse more often and had higher rates of hospi-
talizations as well as a more sever history of NSSI [14]. 
With regards to suicide, it has been shown that the risk 
of suicide was significantly increased in individuals pre-
senting to an emergency room with self-harm [3] and 
in individuals with self-cutting in other body areas than 
arms and wrists [15]. By combining different concepts, 
Hamza et al. [16] provided an integrated model of NSSI 
and suicidal behavior, proposing that NSSI predict sui-
cidal behavior (Gateway theory), with the association 
between NSSI and suicidality being influenced by third 
variables like BPD (Third Variable Theory) and that NSSI 
will change the acquired capability to commit suicide.
An increasing amount of literature has identified risk 
factors for NSSI. By reviewing data from longitudinal 
studies, female gender, previous NSSI, a history of a sui-
cide attempt or psychiatric disorders were reported most 
often [17]. Using a meta-analytic approach to identify risk 
factors for NSSI, previous NSSI, hopelessness, Cluster B 
symptoms and prior suicidal thoughts or attempts were 
identified as strongest risk factors [18]. From an inpatient 
sample of 72 female adolescents alexithymia was identified 
as risk factor for NSSI according to DSM 5 diagnosis [19]. 
It seems that NSSI itself is also a risk factor, not only for 
recurrent NSSI (as stated above), but also for interpersonal 
stressful life events, with the frequency of NSSI predicting 
the number of interpersonal stressors among girls [20].
NSSI is a prominent and frequent phenomenon with 
rates of repetitive and single occurrence around 18% 
in adolescents from community samples worldwide 
[21, 22] and self-evident higher rates of around 50% 
in child and adolescent psychiatric inpatients [23]. A 
recent Cochrane review focuses on children and ado-
lescents with self-harm, but not specifically with NSSI 
[24]. Likewise, the National Institute for Health and 
Care Excellence (NICE) presented a quality standard 
for the care of patients presenting with self-harm [25]. 
However, although consensus based approaches on 
NSSI have been addressed to inform the public about 
the management of people with self-harm [26], specific 
guidelines on NSSI for health care providers are still 
lacking.
Germany has seen especially high rates of NSSI. In 
community samples of adolescents, lifetime prevalence of 
single or repetitive NSSI is reported to be between 25 and 
35% [27, 28], representing the second highest prevalence 
rate in Europe [28] and the highest in German speaking 
countries [29]. It remains unclear, why this is the case, 
as suicide rates (which had been discussed as an expla-
nation) do not correspond to NSSI rates on a national 
level [29] and will be a minimum estimate as some of 
those who would have been recorded as NSSI will have 
died as an unintended consequence of actions that were 
high-lethality but of low suicidal intent. These numbers 
induce an urgent need to provide evidence based guide-
lines for diagnostic assessment and treatment of NSSI in 
adolescents. Therefore, the German Society of Child and 
Adolescent Psychiatry, Psychosomatic and Psychother-
apy (DGKJP) set out to coordinate national guidelines on 
NSSI in adolescents.
Methods
As literature on the treatment process in NSSI is still lim-
ited, a consensus based approach was chosen. This deci-
sion was based on the guideline process as proposed by 
the association of the scientific medical societies 
(AWMF) in Germany, which is the largest organization 
coordinating guideline development on a national level.1 
For the process of guideline development, a group of rep-
resentatives from professional organizations involved in 
the treatment of NSSI in adolescents was formed. During 
initial meetings, this group decided which questions 
needed to be addressed. To assure coverage of relevant 
facts from different areas of NSSI intervention and 
research, different stakeholders (treatment providers, an 
1 http://www.awmf.org/leitlinien/awmf-regelwerk/ll-entwicklung/awmf-
regelwerk-01-planung-und-organisation/po-stufenklassifikation/klassifika-
tion-s2e-und-s2k.html.
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organization representing patient´s needs, organizations 
involved with prevention) were part of the group. The 
balance was checked by the AWMF. Questions were for-
mulated in the group. This was followed by a structured 
literature search (for example see Additional file 1: Figure 
S1), leading to diagnostic assessment and treatment rec-
ommendations drawn from empirical data if available. If 
literature was not available, not generalizable to German 
adolescents, or the level of evidence was low, a consensus 
was reached based on clinical knowledge (good clinical 
practice). All recommendations were discussed and 
voted for in a structured consensus conference at the end 
of the guideline development process and the level of 
consensus was documented. All consensus statements 
had to be voted on with all of them reaching 100% 
approval finally. The finished guideline was then sent to 
the boards of professional associations involved in the 
development of the guideline for final consent and has 
been approved by all participating professional 
associations.
The consensus group consisted of members from eleven 
different national professional organizations from the field 
of child and adolescent psychiatry, psychology, psycho-
therapy, pediatrics, and pediatric surgery (see Additional 
file 2: Figure S2). Furthermore, one representative from an 
organization providing prevention work and one repre-
sentative from a self-help organization for people affected 
by NSSI and suicide were part of the consensus group. All 
members had to state their financial sources in a formal-
ized way, which was forwarded to the board of the DGKJP 
to check for potential competing interests.
All clinical recommendations provided below follow a 
grading pattern provided by the AWMF with three dif-
ferent types of recommendations: “should” (strong rec-
ommendation), “ought to” (moderate recommendation) 
and “may be considered” (optional) [30, 31]. All clini-
cal recommendations and their grading (from strong to 
optional recommendations) were voted on, reaching con-
sensus in 100%. The following paper will focus on the rec-
ommendations provided on both diagnostic assessment, 
as well as treatment strategies, which were consented in 
the process of guideline development and are available 
online in German in its full version [32].
Results
Assessment procedures
In clinical contact with adolescents showing NSSI, direct 
communication is the primary form of exploration and 
may be supplemented by standardized questionnaires 
(see Table 1). Although there are several validated ques-
tionnaires on NSSI, they are mostly used in a research 
context. However, they can be of use in complementing 
information on NSSI, by adding a structured assessment 
procedure. If possible, adolescents should be interviewed 
about NSSI without others being present. In addition, 
taking the history should involve external sources such 
as family members. Suicidality must be explored and a 
full mental health assessment should take place, also tak-
ing into account comorbid mental disorders. In addition 
external factors that influence NSSI like family conflicts, 
bullying, school problems etc. should be explored. In pri-
mary contact, the need for immediate medical help needs 
to be evaluated and status of tetanus vaccination needs 
to be explored, to assure safety after self-inflicted open 
wounds. If there is a need for immediate medical inter-
vention (such as surgical intervention), somatic treat-
ment should be prioritized.
Treatment
Therapeutic setting
In principal, treatment should primarily take place in 
an outpatient setting. This is based on the principle of 
keeping up the highest possible level of functioning and 
lowering the impact on every day´s life to allow for con-
tinuity of family and social relationships. However, out-
patient settings should only be used where there is no 
obvious risk to the individual. Apart from safety con-
cerns, there might be other issues, which could influence 
a decision towards treatment in an inpatient or day-treat-
ment setting (see Table 2).
Surgical treatment
It is possible that individuals with NSSI may require 
surgical treatment (e.g. stitches), which should be car-
ried out in a professional and neutral manner (without 
judgmental comments). Whenever other professions 
are involved, trustful cooperation and sharing of infor-
mation between professions (based on the informed 
consent of caregivers and assent of the minor) is crucial 
(see Table 3). A multidisciplinary approach in the surgi-
cal treatment of patients with NSI has also been put for-
ward by authors from the field of surgery, also stating the 
necessity of a satisfactory esthetic outcome [33].
Table 1 Assessment of NSSI
Basic assessment of NSSI should include
 As a first step, somatic assessment should be conducted and physical 
treatment (e.g. surgical dressing) initiated if necessary
 Full mental health assessment with a special emphasis on assessing 
suicidality should be conducted
 Frequency and methods of NSSI should be assessed
 Factors influencing NSSI both within and outside the family (including 
school environment, peer group) should be assessed
As part of the psychological assessment of NSSI: specific questionnaires 
may be considered as support
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Psychotherapy
To date, no randomized controlled trials specifically 
focusing on the treatment of NSSI have been published. 
Although the number of controlled studies on psycho-
therapeutic interventions in NSSI is still limited, evi-
dence on the efficacy of psychotherapy in the treatment 
of NSSI accumulates [34, 35]. In a recent systematic 
review Calear et al. [36] analyzed seven interventions in 
DSH, with three studies describing a significant decrease 
of DSH after the intervention, three studies describing no 
effect and one study reporting a significant effect in favor 
of the control condition. In another recent meta-analysis 
and meta-regression including both data from studies 
in adults and adolescents, no evidence for an efficacy 
for NSSI was reported with the exception of mentaliza-
tion based treatment (MBT) [37]. On the other hand, the 
recent cochrane review on psychosocial interventions for 
self-harm in adults concluded that treatment effects for 
self-harm were observed for cognitive behavioral therapy 
(CBT), group-based-emotion-regulation-psychotherapy, 
mentalization and dialectical behavior therapy (DBT) 
[38]. Looking into literature on adolescents, reduction 
of self-harm has been shown in a randomized controlled 
trial of Dialectical Behavior Therapy for Adolescents 
(DBT-A) [39]. Evidence for the reduction of self-harm 
in treatment studies has also been provided in studies 
on cognitive behavioral therapy (CBT) [40], cognitive 
analytic therapy (CAT) [41], and mentalization based 
treatment for adolescents (MBT-A) [42]. However, none 
of the included trials exclusively focus on NSSI. A rand-
omized, controlled study of CBT in Germany [43], spe-
cifically focusing on NSSI, has recently been finished and 
is awaiting analysis and publication.
When pooling data from several therapeutic stud-
ies, there is a clear signal that psychotherapy is effective 
in reducing NSSI, however without a clear trend for any 
therapeutic approaches being superior [34]. Starting 
from this background, core elements of psychotherapy 
which can be applied throughout different therapeutic 
approaches in the treatment of NSSI in adolescents were 
recommended (see Table 4).
When planning treatment for NSSI, comorbid psy-
chiatric disorders should always be assessed. In every 
individual case, it should be considered whether the 
treatment of NSSI, or the treatment of the comorbid 
disorder should initially be in the focus of the therapy. 
Comorbid disorders should be treated according to cor-
responding guidelines.
Psychopharmacology
Suggestions on psychopharmacological treatment are 
based on the understanding that psychopharmacological 
treatment of NSSI is not to be used as a single treatment 
strategy and needs to be put in the context of a broader 
multimodal, psychotherapeutic treatment frame. Overall, 
studies are lacking on the psychopharmacological treat-
ment of NSSI, especially concerning adolescents [44]. A 
larger body of literature is available for the treatment of 
self-injury, especially in patients with BPD. The available 
Cochrane review on pharmacological treatment in BPD 
however reports that non of the available studies showed 
Table 2 Treatment setting in NSSI
Outpatient treatment of NSSI
 Outpatient treatment should be initiated if the psychological, social, 
and academic (or ability to work) level of functioning is sufficient, an 
ability to cooperate is existent and criteria for inpatient treatment are 
not met
Inpatient treatment of NSSI
 Acutely suicidal patients must be treated in an inpatient setting at a 
Department of Child and Adolescent Psychiatry
 Should be initiated in case of severe bodily harm or situations making 
close supervision necessary
 Ought to be initiated if the environment is detrimental to treatment 
success
 May be considered, if there is no possibility of achieving sufficient diag‑
nostic assessment in an outpatient setting
 May be considered if no outpatient treatment is available
 May be considered if no sufficient treatment response is achieved in an 
outpatient or day treatment setting
Table 3 Surgical treatment of NSSI
In the surgical treatment of NSSI
 The best possible functional and cosmetic result should be strived for
 The intervention should be made as painless as possible
 Emotional responses and judgmental comments should be forborne
 When the patient is receiving treatment outside of child and adolescent 
psychiatry, she/he should be supervised as long as the potential for 
imminent threat has not been assessed
 A child and adolescent consultation should be requested as soon as 
possible
 For patients already in therapy, contact with the therapist ought to be 
sought
Table 4 Core-elements in  the psychotherapeutic treat-
ment of NSSI
The following core elements of the psychotherapeutic treatment of NSSI 
should be considered
 Clear contracts in the case of suicidality or NSSI
 Building commitment for treatment
 Psychoeducation
 Identifying factors that trigger or maintain NSSI
 Providing alternative behavioral skills or problem solving strategies in 
the case of NSSI
 Attention to and treatment of comorbid psychiatric disorders as sug‑
gested in evidence based guidelines
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a significant effect on self-injury [45]. In addition, a more 
recent Cochrane review on the pharmacological treat-
ment of self-harm in adults, reports a lack of data, thus 
not allowing conclusions to be drawn on the efficacy of 
pharmacological interventions [46].
In adolescents, a specific psychopharmacological 
therapy of NSSI cannot be recommended. Nevertheless, 
the need for an acute psychopharmacological interven-
tion in the case of severe inner tension (with an urge to 
self-injure) emerges at times. In this case, pharmacologi-
cal sedation can be used where other approaches have 
proven unsuccessful. As higher rates of NSSI in those 
receiving benzodiazepines have been reported from the 
TORDIA study [47] and another study reported a lack 
of efficacy in treating NSSI with these compounds [48], 
the use of benzodiazepines should be restricted to clearly 
defined cases and weighing the risk–benefit ratio on an 
individual level. This should include evaluation of the set-
ting, as, for example, the effects of benzodiazepines can 
be more easily monitored and controlled within an inpa-
tient setting. Lower potency conventional antipsychotics 
may be administered where preferred and if they are tol-
erated by the patients. Therefore, the decision on phar-
macological treatment is based on personal variables, 
potential interactions with other drugs and the setting.
Recommendations were finally put together to describe 
a clinical treatment pathway, as outlined in an algorithm 
(see Fig.  1). However, these recommendations are not 
evidence-based due to the lack of data in this field.
Prevention
With regards to prevention, the guidelines state that 
due to a current lack of available studies, the efficacy of 
prevention programs cannot be commented. This state-
ment still holds through, despite the rapid development 
of prevention programs in the sector of self-harm. In one 
study, implementing a school-level prevention program 
for NSSI was shown not to cause any iatrogenic effects, 
however the rate of help-seeking in this population was 
unchanged [49]. In the large European SEYLE program, 
no effects of the different preventive strategies employed 
were seen on NSSI, whereas a significant reduction in 
suicide attempts and ideation was reported from a Youth 
Aware of Mental Health Programme [50], findings that 
were also observed in other prevention trials [36]. Up to 
date there is, to the best of our knowledge, still no pre-
vention program showing an effect in preventing NSSI.
Discussion
To the best of our knowledge, these guidelines on NSSI 
present the first approach to provide treatment rec-
ommendations for NSSI for healthcare professionals. 
These recommendations are based on a consensus of 
professional organizations representing several key-play-
ers in the treatment of NSSI. Following a structured con-
sensus process, national guidelines were developed. As 
the importance of NSSI is increasing—with high preva-
lence rates in adolescents coupled with the inclusion of 
NSSI in Section three of DSM 5—knowledge about best-
practice models of NSSI are urgently needed.
So far, there have been some approaches trying to 
provide guidelines for the treatment of self-harm. Kelly 
and colleagues [26] provided mental health first aid 
guidelines for the treatment of “deliberate nonsuicidal 
self-injury” (comparable to a NSSI definition), based on 
a consensus process involving 26 professionals, 16 peo-
ple, who had engaged in NSSI and three people provid-
ing care for people with NSSI. After defining deliberate 
self-injury and describing different methods, the guide-
line provides recommendations about how to approach 
self-injuring individuals and when mental healthcare 
should be obtained. As these guidelines’ focus is on 
mental health first aid, their advice  is for the general 
public, they do not, therefore, provide details on opti-
mal treatment choice or administration. Following this 
line of recommendations, the NICE quality standard for 
self-harm [25] also focus on the first response to self-
harm in the initial assessment as well as on the preven-
tion of its recurrence. It has to be kept in mind that as 
the NICE quality statement´s focus is on self-harm, it 
also includes reactions to behavior undertaken without 
or with suicidal intent. The NICE statement proposes 
that all patients should be offered psychosocial and risk 
assessment. This should include “physical health, men-
tal state, safeguarding concerns, social circumstances 
and risk of further self-harm or suicide” [25, Statement 
2]. Comprehensive psychosocial assessments should 
identify “personal factors that might explain an act of 
self-harm” [25, Statement 3] and should be provided by 
a “healthcare professional” [25, Statement 3]. It is also 
made clear that people, who have self-harmed should 
be monitored in the healthcare setting to reduce the 
risk of self-harm [25 Statement 4]. Regarding assess-
ment, all of these recommendations are comparable to 
those suggested in the here presented German consen-
sus guidelines on NSSI. The list of quality statements as 
taken from the NICE quality standards [25] is fully in 
line and allows many cross-comparisons to the German 
consensus based guidelines, with regards to statements 
about assessment and monitoring for individuals pre-
senting with self-harm. Recommendations about further 
therapeutic interventions are stated in a sense that peo-
ple with self-harm should have a “discussion with their 
lead healthcare professional about the potential benefits 
of psychological interventions specifically structured 
for people who self-harm” and a plan on how to gain 
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support during the transition between services should 
be collaboratively developed between the individual pre-
senting with self-harm and the healthcare professional 
[25, Statement 7]. It is stated clearly that service provid-
ers should ensure mechanisms to provide “3–12 sessions 
of a psychological intervention specifically structured for 
people who self-harm” [25, Statement 7]. Statements on 
psychosocial interventions are in line with the German 
consensus guideline presented here and are—beyond 
that—more specific in pointing out that a short-term 
intervention is potentially beneficial to patients present-
ing with self-harm.
Recently, a Cochrane review has been published focus-
ing on interventions for self-harm in children and adoles-
cents [46], including eleven trials with 1126 participants. 
All included studies reported data on psychosocial trials, 
none of pharmacological trials. Authors stated that thera-
peutic assessment increased adherence to treatment, 
whereas it did not affect the repetition of self-harm. 
While many specific treatments failed to show an effect 
NSSI
Medical treatment needed
Mental health assessment with special focus on:
• Suicidality
• mental disorders
• other forms of self-injury/self-harm
• chronicity, frequency, funcon of NSSI
• familial and extrafamilial influences
acute suicidality?
inpaentday-treatment
Medical treatment
(Emergency room/ surgical
treatment/ pediatrics)
unl physically stable
Treatment
severity of injuries
comorbid psychiatric disorders
suicidality
outpaent
yesno
NSSI: first-
me
repeve
NSSI
• psycho-
pathology?
• risk of
repeon?
no
yes
counseling
yesno
Dept. of Child and
Adolescent Psychiatry and
Psychotherapy
Fig. 1 Treatment algorithm for NSSI
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on the repetition of self-harm, MBT-A as well as DBT-A 
were able to show a reduction of the frequency of self-
harm. The authors concluded that results from studies on 
therapeutic assessment, MBT-A, DBT-A and CBT war-
rant further studies [46]. In a recent meta-analysis, Calati 
and Courtet [37] found no evidence for the effectiveness 
of psychotherapeutic treatments other than MBT in the 
treatment of NSSI, whereas a recent Cochrane Review on 
self-harm in adults identified several psychotherapeutic 
approaches to be effective in reducing self harm [38]. As 
to date there is no clear-cut evidence for the superior-
ity of a specific psychotherapeutic approach in treating 
NSSI in adolescents, the guideline group decided on an 
integrative approach. In line with previous recommenda-
tions, the present guidelines for NSSI recommend core 
elements of psychotherapy, e.g. psychoeducation, iden-
tifying triggers and maintaining factors and providing 
alternative skills.
Guideline development did identify several gaps in 
the literature. It may well be that the proposed DSM 5 
definition provides a chance to use a uniform defini-
tion, which will increase comparability between studies. 
This will also serve future research on the neurobiology 
of NSSI, as the suggested diagnostic criteria lend itself to 
be explored using a Research Domain Criteria approach 
[51]. Given the high prevalence of NSSI in adolescents, 
further treatment studies are urgently needed. This 
should also include stepped-care approaches to sup-
port different sub-groups of adolescents who self-injure. 
Furthermore, research on children and adolescents who 
self-injure, living outside their families is lacking. As also 
pointed out by the recent Cochrane review [46], no RCTs 
on the psychopharmacological treatment with NSSI as 
the primary outcome are available. Therefore, recom-
mendations on psychopharmacological treatment are 
based on individual treatment experiences, case reports 
as well as studies using self-harm or NSSI as secondary 
outcomes, often not specific for the age-group of children 
and adolescents.
Conclusions
In conclusion, there is an overlap between recommenda-
tions on the treatment of self-harm as proposed by the 
NICE guidelines and the recommendations provided by 
the consensus based German NSSI guidelines presented 
here. Furthermore, the recommendations are in line with 
a recent systematic review on the treatment literature 
concerning children and adolescents, who self-harm [46]. 
Despite the fact that the new German NSSI guidelines are 
focusing on NSSI specifically and suicidality will be tar-
geted in a separate upcoming guideline, there seems to be 
a joint understanding over and about different nomencla-
torial boundaries (NSSI vs. self-harm). It needs to be borne 
in mind that suicidality and NSSI are not mutually exclu-
sive, thus assessment of suicidal ideation/behavior before, 
during or after NSSI should be the gold standard [52].
The guideline provides a new set of consensus based 
recommendations that can be used to support the devel-
opment of new interventions to aid professionals in the 
management of children and adolescents in great need 
of support. To the best of our knowledge, this is the first 
treatment guideline for the recently created diagnostic 
entity of NSSI in the DSM 5.
Abbreviations
DSM 5: diagnostic and statistical manual, fifth edition; DSH: deliberate self‑
harm; NICE: National Institute for Health and Care Excellence; NSSI: nonsuicidal 
self‑injury; AWMF: Arbeitsgemeinschaft Wissenschaftlich Medizinischer Fach‑
gesellschaften: German association of the scientific medical societies; DBT‑A: 
dialectical behavior therapy for adolescents; CBT: cognitive behavioral therapy; 
CAT: cognitive analytic therapy; MBT‑A: mentalization based treatment for 
adolescents.
Authors’ contributions
PLP coordinated the guideline steering committee, drafted and edited the 
paper; RB was a member of the guideline steering committee and edited the 
paper; JMF was a member of the guideline steering committee and edited 
the paper; RCG supported the guideline steering committee and edited the 
paper; TI was a member of the guideline steering committee and edited the 
paper; MK was a member of the guideline steering committee and edited 
the paper; NDK was a member of the guideline steering committee and 
edited the paper; FR edited the paper, KB coordinated the guideline steering 
committee and edited the paper. All authors read and approved the final 
manuscript.
Author details
1 Dept. of Child and Adolescent Psychiatry and Psychotherapy, Central 
Institute of Mental Health, J5, 68159 Mannheim, Germany. 2 Dept. of Child 
and Adolescent Psychiatry and Psychotherapy, Centre for Psychosocial 
Medicine, University of Heidelberg, Heidelberg, Germany. 3 Dept. of Child 
and Adolescent Psychiatry and Psychotherapy, University of Ulm, Ulm, Ger‑
many. 4 Dept. of Clinical Child and Adolescent Psychology and Psychotherapy, 
University of Koblenz‑Landau, Landau, Germany. 5 Dept. of Psychoanalysis 
and Psychotherapy, Medical University of Vienna, Vienna, Austria. 6 Dept. 
of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, 
University Hospital of Marburg and Philipps‑University Marburg, Marburg, 
Germany. 
Acknowledgements
We would like to acknowledge the work of all other participants involved in 
guideline development (in alphabetic order): Hubertus Adam, Micha Bahr, Hell‑
muth Braun‑Scharm, Elisabeth Brockmann, Elmar Etzersdorfer, Martin Fischer, 
Martin Jung, Klein‑Heßling, Rudi Merod, Sylvia Schaller, Armin Schmidtke, Laura 
Werling.
Competing interests
PLP has received research funding from the German Federal Ministry of 
Education and Research, VW Foundation, Baden‑Wuerttemberg Founda‑
tion, and was involved in a clinical study with Lundbeck Pharmaceuticals. He 
does not receive funding from the pharmaceutical industry, owns no shares 
and is no stockholder in the pharmaceutical industry. He does not have any 
Additional files
Additional file 1: Figure S1. Example for literature search.
Additional file 2: Figure S2. Professional associations involved in guide‑
line development.
Page 8 of 9Plener et al. Child Adolesc Psychiatry Ment Health  (2016) 10:46 
competing interests with regards to this paper. RB has received research fund‑
ing from the German Federal Ministry of Education and Research, the German 
research association, the EU, German Cancer help, Minerva Foundation of the 
Max‑Planck Society, Dietmar Hopp Foundation. He does not receive funding 
from the pharmaceutical industry, owns no shares and is no stockholder in 
the pharmaceutical industry. He does not have any competing interests with 
regards to this paper. JMF has received research funding from the German 
Federal Ministry of Education and Research, the German research association, 
the EU, the German Federal Ministry of Health, the German Federal Ministry of 
Family affairs, the German army, VW Foundation, Baden‑Wuerttemberg Foun‑
dation, European Academy, Pontifical University Gregoriana, Social ministries 
of different states, Christian organizations (Caritas, diocese of Rottenburg‑
Stuttgart, CJD), RAZ, congress funding and honoraria from German research 
association, AACAP, NIMH/NIH, EU, Pro Helvetia, Janssen‑Cilag (J&J), Shire, 
different state ministries, medical associations, different Universities. He owns 
no shares and is no stockholder in the pharmaceutical industry. He does 
not have any competing interests with regards to this paper. RCG declares 
no competing interests with regards to this paper. TI has received research 
funding from the Swiss National Fonds. She does not receive funding from the 
pharmaceutical industry, owns no shares and is no stockholder in the phar‑
maceutical industry. She does not have any competing interests with regards 
to this paper. MK has received research funding from the National Health and 
Medical Research Council (NHMRC), Australia; Innovationsfonds Medicine 
of the state Baden‑Wuerttemberg; Baden‑Wuerttemberg Foundation; Dres. 
Majic/Majic‑Schlez‑Foundation; Marga and Walter Boll Foundation. He owns 
no shares and is no stockholder in the pharmaceutical industry. He does not 
have any competing interests with regards to this paper. NDK declares no 
competing interests with regards to this paper. FR has received research fund‑
ing from the German Federal Ministry of Education and Research, the German 
research association, the EU, German Cancer help, Minerva Foundation of the 
Max‑Planck Society, Innovationsfonds Medicine of the state Baden‑Wuerttem‑
berg, Baden‑Wuerttemberg Foundation, Hector Foundation, SRH Foundation, 
Else Kroener‑Fresenius Foundation, Dietmar Hopp Foundation. He does not 
receive funding from the pharmaceutical industry, owns no shares and is no 
stockholder in the pharmaceutical industry. He does not have any competing 
interests with regards to this paper. KB has received research funding from 
the German Federal Ministry of Education and Research, the German research 
association, the German Federal Ministry of Health, the Phillips‑University Mar‑
burg and the University hospital Gießen and Marburg. She is on an advisory 
board of Lilly (Germany) and has received a presentation honorarium from 
Shire. She is board member of the institute for behavioral therapy and behav‑
ioral medicine (IVV) at the Phillips University of Marburg. She owns no shares 
and is no stockholder in the pharmaceutical industry. She does not have any 
competing interests with regards to this paper.
Availability of data and materials
As this papers does not present original data, this does not apply.
Consent for publication
All authors consented to publication of this paper.
Ethical approval and consent to participate
This paper presents no patient data but the development of a clinical guide‑
line, therefore not ethical approval has been obtained.
Funding
No funding was provided for guideline development. Representatives of 
medical associations participating in guideline meetings received travel costs 
from their respective associations.
Received: 18 July 2016   Accepted: 17 November 2016
References
 1. American Psychiatric Association. Diagnostic and statistical manual of 
mental disorders fifth edition (DSM 5). Washington: American Psychiatric 
Association; 2013.
 2. Skegg K. Self‑harm. Lancet. 2005;366:1471–83.
 3. Hawton K, Bergen H, Cooper J, et al. Suicide following self‑harm: findings 
from the Multicentre Study of self‑harm in England, 2000–2012. J Affect 
Disord. 2015;175:147–51.
 4. Cloutier P, Martin J, Kennedy A, Nixon MK, Muehlenkamp JJ. Characteris‑
tics and co‑occurrence of adolescent nonsuicidal self‑injury and suicidal 
behaviours in pediatric emergency crisis services. J Youth Adolesc. 
2010;39:259–69.
 5. Fox KR, Millner AJ, Franklin JC. Classifying nonsuicidal overdoses: 
nonsuicidal self‑injury, suicide attempts, or neither? Psychiatry Res. 
2016;244:235–42.
 6. Power GP, Spencer AP. Parasuicidal behaviour of detained scottish young 
offenders. Int J Offender Ther Comp Criminol. 1987;31:227–35.
 7. Kapur N, Cooper J, O’Connor RC, Hawton K. Non‑suicidal self‑injury v. 
attempted suicide: new diagnosis or false dichotomy. Br J Psychiatry. 
2013;202:326–8.
 8. Plener PL, Fegert JM. Non‑suicidal self‑injury: state of the art perspective 
of a proposed new syndrome for DSM V. Child Adolesc Psychiatry Ment 
Health. 2012;6:9.
 9. Wilkinson P, Goodyer I. Non‑suicidal self‑injury. Eur Child Adolesc Psychia‑
try. 2011;20:103–8.
 10. Zetterqvist M, The DSM. 5 diagnosis of nonsuicidal self‑injury disorder: a 
review of the empirical literature. Child Adolesc Psychiatry Ment Health. 
2015;9:1.
 11. Andover MS, Morris BW, Wren A, Bruzzese ME. The co‑occurrence of 
non‑suicidal self‑injury and attempted suicide among adolescents: distin‑
guishing risk factors and psychosocial correlates. Child Adolesc Psychiatry 
Ment Health. 2012;6:11.
 12. Wilkinson P, Kelvin R, Roberts C, Dunicka B, Goodyer I. Clinical and psy‑
chosocial predictors of suicide attempts and nonsuicidal self‑injury in the 
adolescent depression antidepressants and psychotherapy trial (ADAPT). 
Am J Psychiatry. 2011;168:495–501.
 13. Groschwitz RC, Kaess M, Fischer G, Ameis N, Schulze UME, Brunner R, 
Koelch M, Plener PL. The association of non‑suicidal self‑injury and 
suicidal behavior according to DSM 5 in adolescent psychiatric inpatients. 
Psychiatry Res. 2015;228:454–61.
 14. Boxer P. Variations in risk and treatment factors among adolescents 
engaging in different types of deliberate self‑harm in an inpatient sam‑
ple. J Clin Child Adolesc Psychol. 2010;39:470–80.
 15. Carroll R, Thomas KH, Bramley K, Williams S, Grifin L, Potokar J, Gun‑
nell D. Self‑cutting and risk of subsequent suicide. J Affect Disord. 
2016;192:8–10.
 16. Hamza CA, Stewart SL, Willoughby T. Examining the link between non‑
suicidal self‑injury and suicidal behavior: a review of the literature and an 
integrated model. Clin Psychol Rev. 2012;32:482–95.
 17. Plener PL, Schuhmacher T, Munz LM, Groschwitz RC. The longitudinal 
course of non‑suicidal self‑injury and deliberate self‑harm: searching 
for predictors: a systematic review of the literature. Borderline Personal 
Disord Emot Dysregul. 2015;2:2.
 18. Fox KR, Franklin JC, Ribeiro JD, Kleiman EM, Bentley KH, Nock MK. 
Meta‑analysis of risk factors for nonsuicidal self‑injury. Clin Psychol Rev. 
2015;42:156–67.
 19. Lüdtke J, In‑Albon T, Michel C, Schmid M. Predictors for DSM 5 non‑
suicidal self‑injury in female adolescent inpatients: the role of child‑
hood maltreatment, alexithymia, and dissociation. Psychiatry Res. 
2015;239:346–52.
 20. Burke TA, Hamilton JL, Abramson LY, Alloy LB. Non‑suicidal self‑injury 
prospectively predicts interpersonal stressful life events and depressive 
symptoms among adolescent girls. Psychiatry Res. 2015;228:416–24.
 21. Muehlenkamp JJ, Claes L, Havertape L, Plener PL. International preva‑
lence of adolescent nonsuicidal self‑injury and deliberate self harm. Child 
Adolesc Psychiatry Ment Health. 2012;6:10.
 22. Swannell SV, Martin GE, Page A, Hasking P, St John NJ. Prevalence of 
nonsuicidal self‑injury in nonclinical samples: systematic review, meta‑
analysis and meta‑regression. Suicide Life Threat Behav. 2014;44:273–303.
 23. Kaess M, Parzer P, Mattern M, et al. Adverse childhood experiences and 
their impact on frequency, severity, and the individual function of non‑
suicidal self‑injury in youth. Psychiatr Res. 2013;206:265–72.
 24. Hawton K, Witt KG, Taylor Salisbury TL, Arensmann E, Gunnell D, 
Townsend E, van Heeringen K, Hazell P. Interventions for self‑harm in chil‑
dren and adolescents. Cochrane Database Syst Rev. 2015;12:CD012013. 
doi:10.1002/14651858.CD012013.
Page 9 of 9Plener et al. Child Adolesc Psychiatry Ment Health  (2016) 10:46 
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
 25. National Institute for Health and Care Excellence. Self‑harm: quality 
standard. 2013. https://www.nice.org.uk/guidance/qs34/resources/self‑
harm‑2098606243525. Accessed 13 June 2016.
 26. Kelly CM, Jorm AF, Kitchener BA, Langlands RL. Development of mental 
health first aid guidelines for deliberate nonsuicidal self‑injury: a Delphi 
study. BMC Psychiatry. 2008;8:62.
 27. Plener PL, Libal G, Keller F, Fegert JM, Muehlenkamp JJ. An international 
comparison of adolescent nonsuicidal self‑injury (NSSI) and suicide 
attempts: Germany and the USA. Psychol Med. 2009;39:1549–58.
 28. Brunner R, Kaess M, Parzer P, et al. Life‑time prevalence and psychosocial 
correlates of adolescent direct self‑injurious behavior: a comparative 
study of findings in 11 European countries. J Child Psychol Psychiatry. 
2014;55:337–48.
 29. Plener PL, Fischer CJ, In‑Albon T, Rollett B, Nixon MK, Groschwitz RC, 
Schmid M. Adolescent non‑suicidal self‑injury (NSSI) in German‑speaking 
countries: comparing prevalence rates from three community samples. 
Soc Psychiatry Psychiatric Epidemiol. 2013;48:1439–45.
 30. Nast A, Sporbeck B, Jacobs A, Erdmann R, Roll S, Sauerland U, Rosumeck 
S. Wahrnehmung der Verbindlichkeit von Leitlinienempfehlungen. Dt 
Ärzteblatt. 2013;110:663–8.
 31. Kopp IB, Rahn KH. Leitlinien in der klinischen Praxis: Erkennen worauf es 
ankommt. Bayrisches Ärzteblatt. 2015;1–2:8–12.
 32. Deutsche Gesellschaft für Kinder‑ und Jugendpsychiatrie, Psychoso‑
matik und Psychotherapie. Leitlinie Nicht‑Suizidales Selbstverletzendes 
Verhalten (NSSV) im Kindes‑ und Jugendalter. 2016. http://www.awmf.
org/uploads/tx_szleitlinien/028‑029l_S2k_Nicht‑suizidales‑selbstver‑
letzendes_Verhalten_NSSV_2016‑04.pdf. Accessed 2 June 2016.
 33. Malaga EG, Aguilera EMM, Eaton C, Ameerally P. Management of self‑
harm injuries in the maxillofacial region: a report of 2 cases and review of 
the literature. J Oral Maxillofac Surg. 2016;74:1198.e1–9.
 34. Ougrin D, Tranah T, Stahl D, Moran P, Asarnow JR. Therapeutic interven‑
tions for suicide attempts and self‑harm in adolescents: systematic review 
and meta‑analysis. J Am Acad Child Adolesc Psychiatry. 2015;54:97–107.
 35. Glenn CR, Franklin JC, Nock MK. Evidence‑based psychosocial treatments 
for self‑injurious thoughts and behaviors in youth. J Clin Child Adolesc 
Psychol. 2015;44:1–29.
 36. Calear AL, Christensen H, Freeman A, Fenton K, Busby Grant J, Spijker B, 
Donker T. A systematic review of psychosocial suicide prevention inter‑
ventions for youth. Eur Child Adolesc Psychiatry. 2016;25:467–82.
 37. Calati R, Courtet P. Is psychotherapy effective for reducing suicide 
attempt and non‑suicidal self‑injury rates? Meta‑analysis and meta‑
regression of literature data. J Psychiatr Res. 2016;79:8–20.
 38. Hawton K, Witt KG, Taylor Salisbury TL, Arensman E, Gunnell D, Hazell P, 
Townsend E, van Heeringen K. Psychosocial interventions for self‑harm in 
adults. Cochrane Database Syst Rev. 2016;5:CD012189.
 39. Mehlum L, Ramberg M, Tørmoen AJ, et al. Dialectical behavior therapy 
compared with enhanced usual care for adolescents with repeated 
suicidal and self‑harming behavior: outcomes over a 1‑year follow‑up. J 
Am Acad Child Adolesc Psychiatry. 2016;55:295–300.
 40. Taylor LMW, Oldershaw A, Richards C, Davidson K, Schmidt U, Simic M. 
Development and pilot evaluation of a manualized cognitive‑behavioural 
treatment package for adolescent self‑harm. Behav Cogn Psychother. 
2011;39:619–25.
 41. Chanen AM, Jackson HJ, McCutcheon LK. Early intervention for ado‑
lescents with borderline personality disorder using cognitive analytic 
therapy: randomised controlled trial. Br J Psychiatry. 2008;193:477–84.
 42. Rossouw TI, Fonagy P. Mentalization‑based treatment for self‑harm in 
adolescents: a randomized controlled trial. J Am Acad Child Adolesc 
Psychiatry. 2012;51:1304–13.
 43. Fischer G, Brunner R, Parzer P, Resch F, Kaess M. Short‑term psychothera‑
peutic treatment in adolescents engaging in nonsuicidal self‑injury: a 
randomized controlled trial. Trials. 2013;14:294.
 44. Plener PL, Libal G, Fegert JM, Kölch MG. Psychopharmakologische 
Behandlung von nicht‑suizidalem selbstverletzendem Verhalten (NSSV). 
Nervenheilkunde. 2013;32:38–45.
 45. Stoffers J, Völlm BA, Rücker G, Timmer A, Huband N, Lieb K. Pharmacologi‑
cal interventions for borderline personality disorder. Cochrane Database 
Syst Rev. 2010;16:CD005653.
 46. Hawton K, Witt KG, Taylor Salisbury TL, Arensman E, Gunnell D, Hazell P, 
Townsend E, van Heeringen K. Pharmacological interventions for self‑
harm in adults. Cochrane Database Syst Rev. 2015;7:CD011777.
 47. Brent DA, Emslie GJ, Clarke GN, et al. Predictors of spontaneous and 
systematically assessed suicidal adverse events in the treatment of 
SSRI‑resistant depression in adolescents (TORDIA) study. Am J Psychiatry. 
2009;166:418–26.
 48. Rothschild AJ, Shindul‑Rothschild JA, Viguera A, Murray M, Brewster S. 
Comparison of the frequency of behavioural disinhibition on alprazolam, 
clonazepam, or no benzodiazepine in hospitalized psychiatric patients. J 
Clin Psychopharmacol. 2000;20:7–11.
 49. Muehlenkamp JJ, Walsh BW, McDade M. Preventing non‑suicidal self‑
injury in adolescents: the signs of self‑injury program. J Youth Adolesc. 
2010;39:306–14.
 50. Wasserman DM, Hoven CW, Wasserman C, Wall M, Eisenberg R, Hadlaczky 
G, Kelleher I, Sarchiapone M, Apter A, Balazs, Bobes J, Brunner R, Corcoran 
P, Cosman D, Guillemin F, Haring C, Iosue M, Kaess M, Kahn JP, Keeley H, 
Musa GJ, Nemes B, Postuvan V, Saiz P, Reiter‑Theil S, Varnik A, Varnik P, Carli 
V. School‑based suicide prevention programmes: the SEYLE cluster‑
randomised, controlled trial. Lancet. 2015;385:1536–44.
 51. Westlund Schreiner MW, Klimes‑Dougan B, Begnel ED, Cullen KR. 
Conceptualizing the neurobiology of non‑suicidal self‑injury from the 
perspective of the Research Domain Criteria Project. Neurosci Biobehav 
Rev. 2015;57:381–91.
 52. Kapusta ND. Nonsuicidal self‑injury and suicide risk assessment, quo vadis 
DSM‑V? Suicidol Online. 2012;3:1–3.
